CIK: 0001358331 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 11, 2022
Total Value ($000): $489,080 (95.7% shares, 4.3% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UHAL | Amerco | 75,355 | $44,982 | 9.2% | $21.49 | +186.8% | Common | 023586100 |
| — | Nextera Energy | 490,000 | $41,507 | 8.5% | $80.80 | — | Common | 302571104 |
| ABBV | Abbvie | 243,500 | $39,473 | 8.1% | $47.22 | +167.7% | Common | 00287Y109 |
| ALL | Allstate | 279,300 | $38,685 | 7.9% | $46.67 | +144.9% | Common | 020002101 |
| CMS | CMS Energy | 468,500 | $32,766 | 6.7% | $25.17 | +128.4% | Common | 125896100 |
| DUK | Duke Energy | 286,200 | $31,957 | 6.5% | $47.24 | +88.8% | Common | 26441C204 |
| — | Bausch Health | 1,381,000 | $31,555 | 6.5% | $18.84 | — | Common | 91911K102 |
| XEL | XEL Energy | 412,500 | $29,770 | 6.1% | $24.91 | +142.4% | Common | 98389B100 |
| PFE | Pfizer | 542,700 | $28,095 | 5.7% | $18.94 | +124.3% | Common | 717081103 |
| — | Merck | 323,700 | $26,559 | 5.4% | $47.97 | — | Common | 589331107 |
| AAPL | Apple | 137,400 | $23,991 | 4.9% | $86.19 | +91.2% | Common | 037833100 |
| T | AT & T | 922,000 | $21,786 | 4.5% | $14.91 | 0.0% | Common | 00206R102 |
| ABT | Abbott | 167,600 | $19,837 | 4.1% | $33.85 | +240.8% | Common | 002824100 |
| — | Paratek | 16,600,000 | $14,608 | 3.0% | $0.89 | — | Cv 4.75% | 699374AA2 |
| — | GE | 104,375 | $9,550 | 2.0% | $10.02 | — | Common | 369604103 |
| AVA | Avista | 205,000 | $9,255 | 1.9% | $21.15 | +72.7% | Common | 05379B107 |
| SUPN | Supernus | 222,105 | $7,178 | 1.5% | $28.47 | +7.7% | Common | 868459108 |
| NEM | Newmont | 65,000 | $5,164 | 1.1% | $27.95 | +114.8% | Common | 651639106 |
| — | XM Sirius | 757,843 | $5,016 | 1.0% | $3.50 | — | Common | 82968B103 |
| — | Paratek | 1,557,312 | $4,625 | 0.9% | $4.84 | — | Common | 699374302 |
| EDAP | EDAP | 565,652 | $4,100 | 0.8% | $2.73 | — | Common | 268311107 |
| — | Acorda Theraputics | 5,000,000 | $3,750 | 0.8% | $0.83 | — | Cv 6.0% | 00484MAB2 |
| — | Amryt | 315,182 | $2,603 | 0.5% | $12.09 | — | Common | 03217L106 |
| — | Ashland | 25,000 | $2,460 | 0.5% | $97.00 | — | Common | 044209104 |
| FATE | Fate Theraputics | 57,000 | $2,209 | 0.5% | $22.84 | +69.5% | Common | 31189P102 |
| — | Accelerate Diagnostic | 3,000,000 | $1,980 | 0.4% | $0.66 | — | Cv 2.5% | 00430HAB8 |
| — | IGM Bioscience | 55,000 | $1,470 | 0.3% | $83.20 | — | Common | 449585108 |
| MNKD | Mannkind | 395,073 | $1,453 | 0.3% | $4.01 | -8.8% | Common | 56400P706 |
| OGN | Organon | 31,970 | $1,116 | 0.2% | $26.28 | +8.7% | Common | 68622V106 |
| VTRS | Viatris | 61,512 | $669 | 0.1% | $11.72 | -5.7% | Common | 92556V106 |
| — | Novavax | 600,000 | $642 | 0.1% | $0.61 | — | Cv 3.75% | 670002AB0 |
| RLI | RLI | 2,400 | $269 | 0.1% | $12.47 | +261.5% | Common | 749607107 |